See every side of every news story
Published loading...Updated

Veeda Lifesciences Invests in Mango Sciences for AI-Driven Clinical Trials Innovation

GUJARAT, INDIA, JUL 8 – Veeda Lifesciences aims to improve clinical trial efficiency and diversity using Mango Sciences' AI platform, targeting reduced costs and broader patient representation, executives said.

Summary by Devdiscourse
Veeda Lifesciences is investing in Mango Sciences to enhance its clinical trial services through AI technology. This partnership aims to improve patient recruitment and streamline processes, particularly in oncology, by leveraging Mango's Querent™ platform. This strategic move strengthens Veeda's position in the CRO sector.

7 Articles

All
Left
Center
2
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Tuesday, July 8, 2025.
Sources are mostly out of (0)